uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Kinselby
Opinion
Human
Orphan medicine
Details
EMA number
EMEA/H/C/006259
ATC code
L01X
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of patients with advanced stage mycosis fungoides (MF) and Sézary syndrome (SS)
MeSH:
Mycosis Fungoides;Sezary Syndrome
Group:
Other antineoplastic agents
Active substances
resminostat mesilate
Marketing Authorisation Holder
4Sc AG
MAH
Kinselby | uMedical